Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 13,491,000 | 13,007,000 | 18,486,000 | 25,134,000 | 22,638,000 |
| Cost of Goods | 9,269,000 | 3,237,000 | 4,886,000 | 9,649,000 | 6,063,000 |
| Gross Profit | 4,222,000 | 9,770,000 | 13,600,000 | 15,485,000 | 16,575,000 |
| Operating Expenses | 7,393,000 | 7,576,000 | 7,056,000 | 10,259,000 | 7,632,000 |
| Operating Income | -3,171,000 | 2,194,000 | 6,544,000 | 5,226,000 | 8,943,000 |
| Other Income | -181,000 | 75,000 | -274,000 | 5,000 | 58,000 |
| Pre-tax Income | -3,352,000 | 2,269,000 | 6,270,000 | 5,231,000 | 9,001,000 |
| Income Tax | -964,000 | -71,000 | 715,000 | 230,000 | 356,000 |
| Net Income Continuous | -2,388,000 | 2,340,000 | 5,555,000 | 5,000,000 | 8,645,000 |
| Net Income Discontinuous | 12,000 | -2,000 | 1,000 | 2,000 | -21,000 |
| Minority Interests | 6,000 | 11,000 | 13,000 | 8,000 | 15,000 |
| Net Income | $-2,382,000 | $2,327,000 | $5,543,000 | $4,995,000 | $8,608,000 |
| EPS Basic Total Ops | -0.42 | 0.41 | 0.98 | 0.88 | 1.54 |
| EPS Basic Continuous Ops | -0.42 | 0.41 | 0.98 | 0.89 | 1.54 |
| EPS Diluted Total Ops | -0.42 | 0.41 | 0.97 | 0.86 | 1.51 |
| EPS Diluted Continuous Ops | -0.42 | 0.41 | 0.97 | 0.86 | 1.51 |
| EBITDA(a) | $-1,611,000 | $3,767,000 | $8,031,000 | $6,745,000 | $10,126,000 |